Aveanna Healthcare (NASDAQ:AVAH) Announces Earnings Results

Aveanna Healthcare (NASDAQ:AVAH) issued its quarterly earnings results on Thursday. The company reported $0.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.07 by $0.08, FiscalAI reports. Aveanna Healthcare had a negative return on equity of 103.46% and a net margin of 3.29%.The business had revenue of $621.94 million during the quarter, compared to analyst estimates of $578.57 million. Aveanna Healthcare updated its FY 2025 guidance to EPS.

Aveanna Healthcare Stock Performance

Shares of NASDAQ:AVAH traded up $0.12 on Friday, reaching $8.75. The company’s stock had a trading volume of 1,381,278 shares, compared to its average volume of 1,771,923. The company has a 50-day simple moving average of $8.86 and a 200 day simple moving average of $6.50. Aveanna Healthcare has a 52-week low of $3.67 and a 52-week high of $10.32. The company has a market cap of $1.83 billion, a P/E ratio of 24.31 and a beta of 2.04.

Insider Activity

In related news, major shareholder Paul R. Vigano sold 1,500,000 shares of the stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $9.00, for a total value of $13,500,000.00. Following the completion of the transaction, the insider owned 362,746 shares of the company’s stock, valued at approximately $3,264,714. This trade represents a 80.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 1,251,909 shares of the business’s stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $9.00, for a total value of $11,267,181.00. Following the sale, the insider directly owned 19,292,787 shares in the company, valued at $173,635,083. The trade was a 6.09% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 32,597,968 shares of company stock worth $293,381,712. 7.80% of the stock is currently owned by corporate insiders.

Institutional Trading of Aveanna Healthcare

Institutional investors have recently bought and sold shares of the stock. Quantbot Technologies LP bought a new position in Aveanna Healthcare during the second quarter valued at $43,000. Oxford Asset Management LLP purchased a new position in shares of Aveanna Healthcare during the 2nd quarter worth about $64,000. Bayesian Capital Management LP purchased a new position in shares of Aveanna Healthcare during the 2nd quarter worth about $85,000. Invesco Ltd. grew its holdings in Aveanna Healthcare by 31.1% during the 2nd quarter. Invesco Ltd. now owns 20,006 shares of the company’s stock valued at $105,000 after purchasing an additional 4,742 shares during the last quarter. Finally, Envestnet Asset Management Inc. purchased a new stake in Aveanna Healthcare in the 3rd quarter worth about $182,000. 87.96% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts recently issued reports on AVAH shares. Truist Financial lifted their target price on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a research note on Friday. Barclays upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $5.50 to $9.50 in a research report on Tuesday, August 19th. JPMorgan Chase & Co. raised shares of Aveanna Healthcare from an “underweight” rating to a “neutral” rating and boosted their target price for the stock from $6.00 to $10.00 in a report on Thursday, September 18th. Zacks Research cut shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 20th. Finally, Royal Bank Of Canada lifted their price target on shares of Aveanna Healthcare from $8.00 to $10.00 and gave the company a “sector perform” rating in a report on Friday, October 24th. Three research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $10.07.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.